Partial response after transcatheter arterial infusion chemotherapy in a patient with systemic chemotherapy-resistant unresectable colon cancer and hepatic metastasis: (case report)

World Journal of Surgical Oncology

Volumn 11, Issue , 2013, Pages

  Sawai, Katsuji ^a   Goi, Takanori ^a   Koneri, Kenji ^a   Katayama, Kanji ^a   Yamaguchi, Akio ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

Hepatic arterial infusion chemotherapy; Resistance to systemic chemotherapy; Unresectable colon cancer

Indexed keywords

BEVACIZUMAB; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

APPETITE; ARTERY BLOOD FLOW; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RESISTANCE; COLON CANCER; FOLLOW UP; GASTRODUODENAL ARTERY; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INOPERABLE CANCER; JAUNDICE; LIVER FAILURE; LIVER FUNCTION; LIVER METASTASIS; LUNG CANCER; LUNG METASTASIS; MALAISE; MULTIPLE CYCLE TREATMENT; OUTPATIENT CARE; PERIPHERAL EDEMA; POSTOPERATIVE CARE; SIDE EFFECT; SIGMOIDECTOMY; TREATMENT DURATION; TREATMENT RESPONSE; WALKING DIFFICULTY;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRA-ARTERIAL; LEUCOVORIN; LIVER FAILURE; LIVER NEOPLASMS; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; PROGNOSIS; REMISSION INDUCTION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84881536875     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-11-203     Document Type: Article

References (11)

1. Japanese Society for Cancer of the Colon and Rectum JSCCR Guidelines 2010 for the Treatment of Colorectal Cancer 2010, Tokyo: Kanehara Co, Ltd, Japanese Society for Cancer of the Colon and Rectum.
2. National Cancer Institute-Common toxicity criteria, NCI-CTC Version2.0 April 30, 1999, National Cancer Institute-Common toxicity criteria, NCI-CTC Version2.0.
3. Japanese Society for Cancer of the Colon and Rectum General rules for clinical and pathological studies on cancer of the colon. Rectum and anus 1998, Tokyo: Kanehara & Co, Ltd, 6, Japanese Society for Cancer of the Colon and Rectum.
4. Japanese Society for Cancer of the Colon and Rectum JSCCR Guidelines for Colorectal Cancer Treatment 2005, Tokyo: Kanehara & Co, Ltd, 1, Japanese Society for Cancer of the Colon and Rectum.
5. NCCN Clinical Practice Guidelines in Oncology. Antiemesis V.2.2010 http://www.nccn.org/professionals/physician-gls/PDF/antiemesis, NCCN Clinical Practice Guidelines in Oncology. Antiemesis.
6. Goi T, Sawai K, Koneri K, Katayama K, Yamaguchi A. Results of hepatic arterial infusion chemotherapy in patients with unresectable liver metastases. Viszeralmedizin 2011, 27:397-401.
7. Simone M, Pierluigi P, Mario L, Donato N. Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era?. J Clin Oncol 2007, 25:5649-5654. 10.1200/JCO.2007.12.1764, 18065736.
8. Chen Y, Yan Z, Wang J, Wang X, Luo J, Liu Q. Hepatic arterial infusion with oxaliplatin, irinotecan and doxifluridine for unresectable liver metastases of colorectal cancer. Anticancer Res 2010, 30:3045-3049.
9. Kemeny NE, Huitzil Melendez FD, Capanu M, Paty PB, Fong Y, Schwartz LH, Jarnagin WR, Patel D, D'Angelica M. Conversion to respectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol 2009, 27:3465-3471. 10.1200/JCO.2008.20.1301, 3646304, 19470932.
10. Boige V, Malka D, Elias D, Castaing M, De Baere T, Goere D, Dromain C, Pocard M, Ducreux M. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure. Ann Surg Oncol 2008, 15:219-226. 10.1245/s10434-007-9581-7, 17896145.
11. Gallagher DJ, Capanu M, Raggio G, Kemeny N. Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis. Ann Oncol 2007, 18:1995-1999. 10.1093/annonc/mdm405, 17962209.